2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$59.73+$0.23 (+0.39%)
Price as of Aug 21, 2026 7:59 PM EDT- $5.9BMarket Cap
- 9.54%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$59.73+$0.23 (+0.39%)
Earnings Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -0.13% | ||
12-Month Momentum | -10.02% | ||
3-Month Risk Adjusted Momentum | -0.53% | ||
12-Month Risk Adjusted Momentum | -17.52% |
True Yield
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.71% | ||
Net Debt Paydown Yield | -0.01% |
Financial Health Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |